Atritech, Inc.
Atritech completes $22.5M equity financing
Published in Biotech Law Weekly, April 7th, 2006
It is the largest venture capital raise in the Minnesota medical device industry in the last 20 months. Prism Venture Partners led the round and substantial commitments were received from the existing investors and Tullis-Dickerson, a new investor.
With this capital, the company will complete enrollment in the Protect AF clinical trial.
Atritech's Watchman device is designed to keep harmful sized blood clots from entering a patient's blood stream, potentially causing a stroke. Patients with atrial...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Law Weekly
Source: Biotech Law Weekly (2006-04-07)
More Articles from Biotech Law Weekly
- Advaxis, Inc.
Advaxis receives approvals to commence study of Listeria vaccine for cervical cancer - Arius Research, Inc.
U.S. patent issued to Arius Research for anti-CD63 antibody for cancer treatment - Biophan Technologies, Inc.
Biophan files patent application on use of halloysite nanotubes - Cutting Edge Information
Cutting Edge Information study finds new drug formulations are popular counter-generic strategy - Drug Abuse
NSF International unveils new banned substances certification program for all sports - Drug Abuse
Safeway adds restrictions for pseudoephedrine product sales to curtail meth abuse - More from this issue of Biotech Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
